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Reduced activity of insulin/insulin-like growth factor signaling (IIS)
increases healthy lifespan among diverse animal species. Down-
stream of IIS, multiple evolutionarily conserved transcription fac-
tors (TFs) are required; however, distinct TFs are likely responsible
for these effects in different tissues. Here we have asked which
TFs can extend healthy lifespan within distinct cell types of the
adult nervous system in Drosophila. Starting from published
single-cell transcriptomic data, we report that forkhead (FKH) is
endogenously expressed in neurons, whereas forkhead-box-O
(FOXO) is expressed in glial cells. Accordingly, we find that neuro-
nal FKH and glial FOXO exert independent prolongevity effects.
We have further explored the role of neuronal FKH in a model of
Alzheimer’s disease-associated neuronal dysfunction, where we
find that increased neuronal FKH preserves behavioral function
and reduces ubiquitinated protein aggregation. Finally, using tran-
scriptomic profiling, we identify Atg17, a member of the Atg1
autophagy initiation family, as one FKH-dependent target whose
neuronal overexpression is sufficient to extend healthy lifespan.
Taken together, our results underscore the importance of cell type-
specific mapping of TF activity to preserve healthy function
with age.
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Metazoan life is defined by its diversity of cell types, eachtype maintaining its identity and reacting to its environ-
ment through the cell type-specific action of transcription factors
(TFs) that regulate appropriate gene expression patterns. In
some cases, a single stimulus acts through distinct TFs in dif-
ferent cell types to produce divergent effects. For instance, the
insulin/insulin-like growth factor (IGF) signaling (IIS) pathway
coordinates nutrition with growth and metabolism across tissues
throughout the animal kingdom. Insulin and insulin-like ligands
promote glucose uptake and glycogen synthesis in myocytes,
reduce gluconeogenesis and promote de novo lipogenesis in
hepatocytes, and reduce lipolysis in adipocytes; each cell type
responds through partially overlapping signaling cascades that
exert their long-term effects through distinct combinations of
TFs (1).
While IIS activity is indispensable for proper development and
metabolism, reduced IIS in adult organisms can extend healthy
lifespan in diverse species (2, 3). These findings have prompted
the hypothesis that IIS is a canonical example of antagonistic
pleiotropy, that is, a biological process that has been evolution-
arily favored for its role in youth despite its detrimental effects in
aging (4). Consistent with this hypothesis, multiple interventions
that inhibit IIS, including reduced levels of insulin-like ligands (5,
6), reduced signaling through the insulin receptor and its sub-
strates (7–11), and inhibition of the effector kinases PI3K (12)
and RAS (13), lead to increased healthy lifespan, stress resistance,
and preserved function with age in multiple species. In humans as
well, gene variants that reduce the activity of the IGF1 receptor
are enriched in centenarians (14). With the predicted continued
rise in the proportion of elderly individuals across industrialized
nations (15), a more complete understanding of how IIS modu-
lates aging through diverse cell types is needed to guide effective
therapeutic interventions for the diseases of aging.
Studies at the level of the whole organism, and an increasing
number at the level of individual tissues, have revealed that
transcriptional regulation is essential for the IIS pathway to
mediate its effects on lifespan. Inhibition of Forkhead-box family
TFs, particularly FOXO family members, are the best charac-
terized lifespan-limiting effects of IIS activity (12, 16, 17). Con-
sistent with a prolongevity role for FOXO family members in
humans, single-nucleotide polymorphisms in the FOXO3A gene
are associated with longevity in large-scale genome-wide asso-
ciation studies (18, 19). In addition to FOXO, multiple addi-
tional TFs within the IIS pathway modulate healthy lifespan at
the level of the whole organism, including ETS family members
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(20) and FOXA family members (21). While FOXA family
members have been less extensively studied than FOXO down-
stream of IIS, recent work has shown that IIS activity results in
phosphorylation of the Drosophila FOXA ortholog Forkhead
(FKH) and that FKH can biochemically interact with both AKT
and TOR kinases (21), identifying FKH as a key transcriptional
player within the IIS/TOR signaling network.
Remarkably, modulation of TFs downstream of IIS can extend
lifespan even when restricted to specific tissues (reviewed in ref.
22). Studies in Drosophila have demonstrated increased lifespan
for flies with increased FOXO expression in muscle, gut, and/or
adipose tissues (17, 23, 24), with distinct FOXO-dependent and
-independent prolongevity effects in different tissues (25). Indeed,
within the gut, increased expression of FKH in differentiated in-
testinal cells is sufficient to extend lifespan (21). These studies
suggest that distinct Forkhead family TFs may have specific roles
in modulating healthy lifespan in individual cell types.
Among organ systems, the effects of aging on the nervous
system present particularly important challenges to modern
medicine. The increasing prevalence of the neurodegenerative
diseases of aging is one of the most costly consequences of the
rapidly aging demographic of human populations (26). In some
developed countries, Alzheimer’s disease and related causes of
dementia have now become the leading cause of death (27).
Moreover, IIS activity in the nervous system can directly mod-
ulate healthy lifespan and nervous system function with age. In
mice, IGF1 receptor deletion extends lifespan when restricted to
the nervous system using the nestin-Cre driver line, which ex-
presses in both neurons and glia (the nonneuronal cells of the
nervous system) (28). In flies, IIS inhibition in either neurons
(29, 30) or glia (31) alone is sufficient to extend healthy lifespan,
with neuron-specific interventions able to preserve youthful
electrical transmission in neuronal circuits with age (32). How-
ever, studies to date have not identified which of the TFs down-
stream of IIS can extend healthy lifespan in the nervous system.
Paradoxically, increased FOXO expression in neurons dramati-
cally shortens Drosophila lifespan (17, 20), suggesting that other
TFs may play more protective roles in neurons and/or glia.
To this end, we hypothesize here that accurate mapping of the
TFs endogenously expressed in different cell types could be in-
dicative of their potential to modulate lifespan in a cell type-
specific manner. Drawing on recent single-cell RNA-sequencing
(RNA-seq) profiling of the adult Drosophila brain (33), we show
here that FOXO is endogenously expressed in glia but not neu-
rons, whereas FKH is expressed in neurons but not glia. Consis-
tent with these expression patterns, we show that increased
expression of FOXO in glia and FKH in neurons can extend
healthy lifespan. Moreover, we find that neuronal FKH can pre-
serve function in a Drosophila model of Alzheimer’s disease-
related amyloid-beta (Aβ) toxicity. Finally, using transcriptomic
profiling, we identify increased expression of Atg17, an essential
component of the Atg1 autophagy initiation complex, as one of
the beneficial effects downstream of FKH in neurons in response
to reduced IIS.
Results
FKH, but Not FOXO, Can Extend Lifespan in Drosophila Neurons. To
assess the TFs most likely to modulate lifespan downstream of
IIS in the nervous system, we first examined the endogenous
expression of each TF in neurons and glia using published single-
cell RNA-seq data from adult Drosophila brains (33). We ob-
served that foxo messenger RNA (mRNA) was most highly
expressed in cells expressing the canonical glial TF repo (Fig. 1A),
whereas fkh mRNA was most highly expressed in cells expressing
neuronal Synaptobrevin (nSyb), a canonical neuronally expressed
gene (Fig. 2A). In each case, we confirmed by immunofluores-
cence imaging that glial localization of FOXO and neuronal lo-
calization of FKH matched the transcriptomic data, using either a
green fluorescent protein (GFP)-labeled FOXO protein under the
control of its native promoter (Fig. 1B) or antibody labeling for
FKH (Fig. 2B). These data prompted us to hypothesize that FKH
might have a greater capacity than FOXO in neurons to extend
healthy lifespan.
To directly test this hypothesis, we first tested whether foxo
overexpression in neurons or glia would extend healthy lifespan.
We restricted overexpression of foxo to adulthood by using the
GeneSwitch inducible expression system, which drives expression
of UAS transgenes only when flies are fed the inducing drug
RU-486 (34). Adult-onset overexpression of foxo using the pan-
neuronal elav-GS driver caused a marked shortening of lifespan
(Fig. 1C; median lifespan −18.2% and P = 0.0051 versus uninduced
control), consistent with previous reports (17, 20). However, adult-
onset overexpression of foxo using the pan-glial Glia-GS driver
significantly increased healthy lifespan (Fig. 1D; median lifespan
+8.8% and P = 2.0 × 10−6), a result that was reproducible in
independent experiments (SI Appendix, Fig. S1A) and not ob-
served for flies expressing the Glia-GS driver alone (SI Appendix,
Fig. S1B). In addition, and consistent with previous studies ex-
amining the effects of reduced IIS in glia (31), we observed no
change in fecundity for flies overexpressing FOXO in glia (SI
Appendix, Fig. S1C).
Next, we assessed adult-onset neuronal overexpression of fkh
using elav-GS, which led to a significant increase in lifespan
(Fig. 2C; median lifespan +6.6% and P = 2.3 × 10−7 versus
uninduced control), a result that was similarly reproducible in
independent experiments (SI Appendix, Fig. S2A) and not due to
the elav-GS driver alone (SI Appendix, Fig. S2B). Here again, we
observed no change in fecundity with neuronal FKH over-
expression (SI Appendix, Fig. S2C). We also tested the effects of
glial adult-onset overexpression of fkh using Glia-GS; however,
we observed no significant change in lifespan for these flies
(Fig. 2D; P = 0.40). Taken together, these data indicate that
overexpression of either foxo in glia or fkh in neurons, cell types
in which these TFs are endogenously most highly expressed, can
extend healthy lifespan in ways that TFs not normally expressed
cannot.
Neuronal FKH Does Not Interact with FOXO in Modulating Healthy
Lifespan. Because of the established prolongevity and antiaging
effects of reduced IIS in neurons (28–30, 32) and the reported
roles played by FOXA TFs in adult mammalian dopaminergic
neurons (35), we decided to pursue the role of FKH in neurons
more extensively. We first asked whether neuronal fkh over-
expression would interact with other established prolongevity
pathways. Previous studies have shown that ubiquitous IIS inhi-
bition requires both FOXO and FKH to extend lifespan (12, 21).
However, other studies have shown that foxo overexpression
from the fat body and intestinal tissues does not require foxo
expression in any other tissue to extend lifespan (36). We there-
fore tested whether neuronal FKH would require foxo expression
in other tissues to extend lifespan. We found that, even in a foxo-
null genetic background, neuronal fkh overexpression extended
lifespan to a similar extent in both wild-type and foxoΔ flies
(Fig. 2E; wild-type median lifespan +10.4% and P = 4.5 × 10−5,
foxoΔ median lifespan +8.0% and P = 0.0029). Cox proportional
hazards analysis confirmed that lifespan extension from increased
neuronal FKH expression was independent of FOXO (P = 0.61),
suggesting that, like foxo overexpression in the fat body (36), fkh
overexpression in neurons does not require FOXO-driven tran-
scriptional changes in other cell types to extend healthy lifespan.
Rapamycin is a well-characterized mTOR inhibitor with
established prolongevity effects. Unlike the lifespan extension
derived from ubiquitous IIS inhibition, the prolongevity effects
of rapamycin do not require FOXO (37); in contrast, rapamycin’s
effects on lifespan require FKH presence in the gut (21). To assess
whether fkh in neurons would also be required for rapamycin’s
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effects, we combined RNA interference (RNAi) knockdown of fkh
in adult neurons using elav-GS with rapamycin feeding starting
from 2 d of age. We first found that neuronal fkh knockdown
alone did not significantly alter lifespan (SI Appendix, Fig. S2D;
P = 0.86). However, in contrast to the findings from fkh knock-
down in the gut, rapamycin treatment extended lifespan to the
same extent with or without neuronal fkh knockdown (uninduced
median lifespan +11.6% and P = 9.0 × 10−14, fkh knockdown
median lifespan +11.3% and P = 5.7 × 10−12), with no significant
interaction between neuronal fkh knockdown and rapamycin
treatment (Cox proportional hazards interaction, P = 0.32). Taken
together, these results confirm that increased neuronal FKH is
sufficient to extend lifespan in a FOXO-independent manner.
They also provide preliminary support for potential differences
between neuronal and intestinal FKH function with respect to
pharmacological mTOR inhibition, although additional studies,
for example quantifying additive effects of neuronal FKH and
pharmacological mTOR inhibition, will be necessary to fully
define this interaction.
Overexpression of FKH in Neurons Improves Locomotor Function and
Reduces Protein Aggregation in Aβ-Expressing Flies. Previous studies
have found that chronically reduced IIS can have beneficial ef-
fects on neuronal function during healthy aging and in disease
models: in Drosophila, neuron-specific IIS inhibition pre-
serves youthful neurotransmission during healthy aging (32); in
Caenorhabditis elegans, ubiquitous IIS inhibition slows locomotor
decline in the presence of the human Alzheimer’s disease Aβ
peptide (38); and in mice, ubiquitous IIS inhibition preserves
spatial memory behavior when Aβ is overexpressed in neurons
(39). To determine whether increased fkh expression could
produce similar protective effects against Aβ in neurons, we
turned to an established Drosophila model of neuronal expres-
sion of AβArc, a highly toxic and oligomer-prone form of Aβ
derived from a familial form of Alzheimer’s disease [APPE693G
(40)]. Adult-onset expression of AβArc in neurons produces
marked phenotypes of shortened lifespan and reduced neuro-
muscular function as assessed by the negative geotaxis (climbing)
assay (41).
We first tested whether neuronal fkh overexpression would
protect against neuromuscular decline caused by Aβ. In the ab-
sence of RU-486, we observed no difference in climbing ability
between flies with or without the UAS-fkh transgene (Fig. 3A;
genotype effect P = 0.22 by two-way ANOVA). However, in the
presence of RU-486, we found that flies overexpressing fkh in
neurons were significantly protected from the decline in climbing
activity produced by Aβ (Fig. 3B; genotype effect P = 0.0008 by
two-way ANOVA), a result that was reproducible in indepen-
dent experiments (SI Appendix, Fig. S3). At the same time, we
observed that neuronal fkh overexpression did not produce any
improvement in the shortened lifespan caused by Aβ (Fig. 3C;
P = 0.33 by log-rank test). Notably, these findings are in contrast
to previous findings that dietary restriction increases lifespan of
the same Drosophila Aβ model without producing any improve-
ment in climbing ability (42), revealing additional distinctions
between the prolongevity effects of neuronal fkh overexpression
and dietary treatments that impact nutrient-sensing pathways in
other tissues.
In addition to behavioral impairments, Drosophila models
of neurodegenerative disease are often characterized by the
presence of polyubiquitinated protein aggregates and accumu-
lation of the Drosophila p62/SQSTM1 ortholog REF(2)P (43).
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Fig. 1. Overexpression of foxo in glia, but not neurons, extends lifespan. (A) Images from the SCope database (33) show mRNA expression of foxo largely in
repo-expressing (glial) cell populations in the Drosophila brain. (B) Immunofluorescence images from the cell body layer adjacent to the olfactory bulb in the
central brain show FOXO-GFP expression overlapping with REPO-positive glial cells inwDah;foxo-GFP flies. (Scale bar, 10 μm.) (C and D) Survival curves show (C)
shortened lifespan forwDah;;elav-GS/UAS-foxo flies and (D) extended lifespan forwDah;;GSG3285-1/UAS-foxo flies treated with 200 μM RU-486 from 2 d of age
compared with sibling flies of the same genotype treated with vehicle control food. For all survival experiments, n > 140 deaths were counted per condition;
P values are from log-rank tests between groups.
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To determine whether improved proteostasis may be one mech-
anism by which FKH improves function in Aβ-expressing brains,
we quantified the levels of REF(2)P and polyubiquitinated (FK2
antibody-positive) protein aggregates in fly brains expressing ei-
ther Aβ alone or Aβ with fkh (Fig. 3D). We observed a significant
reduction in the accumulation of both markers with fkh coex-
pression (Fig. 3E), suggesting that FKH can ameliorate the effects
of Aβ on both behavioral decline and protein aggregation in
the brain.
FKH-Dependent Transcriptional Responses to Reduced IIS. To iden-
tify potential beneficial pathways downstream of FKH in neu-
rons, we next turned to a transcriptomic approach. Our previous
studies have shown that FKH function is necessary for reduced
IIS to extend Drosophila lifespan, using ubiquitous RNAi-
mediated fkh knockdown in combination with overexpression
of a dominant-negative kinase-dead form of the Drosophila in-
sulin receptor (InRK1409A, or InRDN) (21). These studies iden-
tified an essential role of fkh in the gut and used RNA-seq from
gut tissue to identify FKH-dependent transcriptional changes in
response to reduced IIS. Given our similar results described
above for neuronal fkh overexpression, we employed the same
strategy from head tissues to identify FKH-dependent tran-
scriptional changes in the nervous system in response to
reduced IIS.
We isolated heads from flies with ubiquitous reduction of IIS
(using the ubiquitous da-GS driver and UAS-InRDN) with or
without RNAi knockdown of fkh. While Drosophila head tissues
contain multiple cell types and some tissues from outside of the
nervous system, we reasoned that this approach would allow us
to see both neuronal and nonneuronal effects of FKH in head
tissues; moreover, roughly 90% of Drosophila brain cells are
neurons (44), so we predicted that our results would be enriched
for neuronal gene expression. To help correct for off-target ef-
fects from ubiquitous activation of the RNAi machinery (45), we
used a UAS-GFP-RNAi transgene as the control condition to
compare with expression of UAS-fkh-RNAi. We first identified
the set of genes differentially expressed in wild-type and
reduced-IIS head extracts (da-GS>UAS-InRDN,UAS-GFP-RNAi






Lifespan: Neuronal FKH (elavGS>fkh)



















p = 2.3 E-07
Lifespan: Glial FKH (GliaGS>fkh)





















Lifespan: Neuronal FKH (elavGS>fkh)




















fkh o/e p = 0.0019
foxo p = 2.6 E-12
Interaction p = 0.61foxo Uninduced
foxo  Induced
DAPI REPO FKH Merge
Fig. 2. Overexpression of fkh in neurons, but not glia, extends lifespan independent of FOXO. (A) Images from the SCope database (33) show mRNA ex-
pression of fkh largely in nSyb-expressing (neuronal) cell populations in the Drosophila brain. (B) Immunofluorescence images from the cell body layer of the
central brain show FKH expression in REPO-negative (neuronal) cells in wDah flies. (Scale bar, 10 μm.) (C–E) Survival curves show (C) extended lifespan for
wDah;UAS-fkh/+;elav-GS/+ flies, (D) no change in lifespan for wDah;UAS-fkh/+;GSG3285-1/+ flies, and (E) extended lifespan for both wDah;UAS-fkh/+;elav-GS/+
and wDah;UAS-fkh/+;elav-GS, foxoΔ/foxoΔ flies treated with 200 μM RU-486 from 2 d of age, with no significant interaction between fkh overexpression and
foxoΔ genotype. For all survival experiments, n > 85 deaths were counted per condition; P values are from either log-rank tests between groups (C and D) or
Cox proportional hazards testing (E).
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RU-486) and the set of genes differentially expressed in reduced-
IIS heads with or without RNAi knockdown of fkh (daGS>UAS-
InRDN,UAS-GFP-RNAi with RU-486 versus daGS>UAS-
InRDN,UAS-fkh-RNAi with RU-486). When looking at the genes
that overlapped between these two comparisons, we found 99
overlapping up-regulated genes and 84 overlapping down-
regulated genes, which represented a highly significant overlap
between comparisons (Fig. 4A; P = 6.32 × 10−45). As previously
observed for gut tissue, these data suggest that a significant pro-
portion of the transcriptional response to reduced IIS in the
nervous system is mediated by FKH.
We next hypothesized that the most promising beneficial
transcriptional responses regulated by FKH in response to re-
duced IIS should be indicated by genes whose expression levels
revert toward wild-type levels upon fkh knockdown in reduced-
IIS flies. We therefore looked at the most significantly up-
regulated and down-regulated genes upon reduced IIS whose
transcriptional changes depended on FKH expression (Fig. 4B
and SI Appendix, Table S1). Among the up-regulated genes, we
identified a number of genes involved in IIS whose expression
reverted toward control levels with fkh knockdown, including
ImpL2, Thor, and foxo, potentially indicative of feedback loops
downstream of IIS that depend on FKH activity. Notably, these
genes and/or their orthologs in other species have all previously
been shown to modulate healthy lifespan (24, 46, 47). In addi-
tion, we noted that expression of Atg17 was markedly increased
upon reduced IIS and significantly reverted toward control levels
with fkh knockdown (Fig. 4B). Drosophila Atg17 encodes a
subunit of the ATG1 kinase complex that initiates autophago-
some formation to regulate the rate of autophagy (48), one of
the central cellular processes that maintains proteostasis and
organelle recycling in nervous system health and neurodegen-
erative diseases (49). We therefore decided to explore further
the role of neuronal Atg17 in fkh-mediated modulation of
longevity.
Atg17 Is a Neuronal FKH Target That Can Extend Healthy Lifespan. To
determine whether increased neuronal Atg17 expression could be
an important beneficial downstream effect of neuronal fkh, we
first tested whether Atg17 levels were increased in long-lived flies
overexpressing neuronal fkh. qPCR analysis on heads isolated
from elavGS>UAS-fkh flies showed a significant ∼42% increase
in Atg17 expression levels (Fig. 5A), consistent with the FKH-
dependent modulation of Atg17 expression we had observed in
our RNA-seq results (Fig. 4B).
We next directly tested whether increased neuronal Atg17
expression would be sufficient to extend healthy lifespan on its
own. We overexpressed Atg17 in adult neurons and observed a
significant increase in lifespan (Fig. 5B; median lifespan +5.4%
and P = 2.9 × 10−6). Importantly, this lifespan extension was
reproducible in independent experiments (SI Appendix, Fig.
S4A). These results were consistent with previous studies show-
ing that up-regulation of other genes in autophagy-related
pathways, including Atg1, can have prolongevity effects (50).
To confirm these published studies, we overexpressed Atg1 in




Fig. 3. Overexpression of fkh in neurons improves neuromuscular function and reduces protein aggregation in the presence of Aβ. (A and B) Climbing assay
results show (A) unaffected neuromuscular function in uninduced (vehicle control) w1118;UAS-AβArc/UAS-fkh;elav-GS/+ flies compared with uninduced
w1118;UAS-AβArc/+;elav-GS/+ flies and (B) improved function in induced (200 μM RU-486) w1118;UAS-AβArc/UAS-fkh;elav-GS/+ flies compared with induced
w1118;UAS-AβArc/+;elav-GS/+ flies. (C) Survival curves show no change in lifespan for induced (200 μM RU-486) w1118;UAS-AβArc/UAS-fkh;elav-GS/+ flies com-
pared with induced w1118;UAS-AβArc/+;elav-GS/+ flies. (D and E) Immunostaining images (D) and quantification (E) show reduced accumulation of REF(2)P and
polyubiquitinated protein (FK2) aggregates in induced w1118;UAS-AβArc/UAS-fkh;elav-GS/+ flies compared with induced w1118;UAS-AβArc/+;elav-GS/+ flies at
28 d of age. For climbing experiments, n = 3 vials of 15 flies per vial per condition; data are displayed as mean ± SEM; for survival experiments, n > 135 deaths
were counted per condition; and for immunofluorescence experiments, n = 4 or 5 brains for uninduced and 11 to 13 brains for induced conditions. P values
are from two-way ANOVA (A and B), log-rank test (C), or Bonferroni multiple comparisons (E).
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both cases, we observed some early mortality but overall signif-
icant increases in both median (+3.1 and +9.8%) and maximum
(+4.2 and +12.7%) lifespan (SI Appendix, Fig. S4 B and C).
Finally, we assessed whether FKH overexpression in neurons
would affect markers for autophagy and proteostasis in young and
aged flies. We first quantified the Drosophila LC3 ortholog ATG8,
in both its unlipidated (ATG8-I) and autophagy-associated lipi-
dated (ATG8-II) forms (SI Appendix, Fig. S5 A–D); however, we
did not observe any significant differences in healthy young flies
and instead observed a decrease in ATG8-II levels in aged flies.
However, the interpretation of LC3/ATG8 levels can be complex,
as sustained increases in autophagy can reduce overall LC3/ATG8
levels in both Becn1F121A/F121A mice (51) and chico-null flies (52).
Moreover, LC3-II/ATG8-II can be difficult to interpret in nervous
system cell types, where increases from its low basal levels can
indicate either increased autophagy or blocked autophagic flux
(53). We therefore quantified the levels of insoluble poly-
ubiquitinated proteins as a secondary readout of proteostasis (SI
Appendix, Fig. S5 E–H); here, we observed no differences in either
young or aged fkh-overexpressing flies. Notably, this was in con-
trast to our results from Aβ-expressing flies (Fig. 3 D and E),
suggesting that FKH may exert its beneficial effects on proteo-
stasis most measurably under conditions of stress or disease.
Taken together, these results suggest that increased Atg17 ex-
pression is one, but likely not the only, beneficial effect of neu-
ronal fkh overexpression, leaving open the possibility for multiple
other pathways that can increase healthy lifespan downstream of
neuronal FKH.
Discussion
Here we have shown that distinct Forkhead family TFs in the
Drosophila nervous system can modulate healthy lifespan through
their activity in different cell types. We have found that FKH,
rather than FOXO, can extend healthy lifespan in neurons,
whereas FOXO appears to be the more relevant Forkhead family
TF for glial cells. We have also demonstrated that increased FKH
activity in neurons can protect against some of the detrimental
effects of Aβ in Drosophila neurons, suggesting that FKH can play
roles not only in healthy lifespan but also in pathways that mod-
ulate toxicity in neurodegenerative diseases. Finally, we have
identified Atg17 as one lifespan-modulating gene downstream of
FKH in neurons in response to reduced IIS, although other
pathways downstream of FKH are very likely to play additional
beneficial roles.
These findings help shed light on an apparent paradox from
previous studies on the modulation of lifespan by neurons: While
decreased IIS in neurons extends healthy lifespan (29), the





























































































































Fig. 4. RNA-seq from head mRNA reveals fkh-dependent transcriptional
responses to reduced IIS. (A) In head mRNA from flies treated with 200 μM
RU-486 or vehicle control from 2 to 5 d of age, the overlap between the
transcriptional response from reduced IIS compared with controls
(daGS>UAS-InRDN,UAS-GFP-RNAi induced versus daGS>UAS-InRDN,UAS-GFP-
RNAi uninduced) and compared with flies with reduced IIS and fkh knock-
down (daGS>UAS-InRDN,UAS-GFP-RNAi induced versus daGS>UAS-
InRDN,UAS-fkh-RNAi induced), revealed 99 shared up-regulated and 84
shared down-regulated genes, which represented a significant overlap be-
tween comparisons (P = 6.3 × 10−45 by Fisher’s exact test). (B) Heatmap shows P
values for the 20 genes most significantly up-regulated or down-regulated
among the shared genes between comparisons.
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Fig. 5. Overexpression of fkh in neurons increases Atg17 expression, and
overexpression of Atg17 in neurons extends lifespan. (A) qPCR from head
RNA shows increased mRNA levels for Atg17 in wDah;UAS-fkh/+;elav-GS/+
flies given food containing 200 μM RU-486 from 2 to 5 d of age. n = 4 or 5
biological replicates of 30 heads per replicate for each condition; the P value
is by unpaired t test. (B) Survival curves show extended lifespan for
wDah;UAS-Atg17/+;elav-GS/+ flies treated with 200 μM RU-486 from 2 d of age.
n > 135 deaths were counted per condition; the P value is by log-rank test.
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canonical downstream effect of increased FOXO activity in
neurons shortens lifespan (17, 20). Based on single-cell tran-
scriptomic data (33) and our immunostaining results from the
adult Drosophila brain, we now suggest that the endogenous
expression patterns of multiple TFs among different cell types
can help inform the interpretation of these results. Specifically,
our results place neurons alongside differentiated intestinal cells
(21) as cell types in which FKH, rather than FOXO, is sufficient
to mediate prolongevity effects. Notably, these results are in
agreement with other recent studies pointing to the limited ex-
pression of FOXO in Drosophila neurons compared with other
cell types (54). Our results also place glial cells alongside the fat
body (24) and some gut cell populations (20) as Drosophila cell
types in which FOXO can mediate similar effects. Our results
also complement our recent findings that glia-specific IIS inhi-
bition can extend healthy lifespan in a FOXO-dependent man-
ner (31). Finally, our results do not exclude the possibility that
other TFs downstream of IIS in the nervous system can modulate
longevity; indeed, recent studies have shown that knockdown of
the ETS family TF Eip74EF in neurons can extend healthy
lifespan (20), and other TFs are likely to play additional roles in
nervous system aging.
Downstream of FKH, our transcriptomic results suggest that,
as was previously observed for gut tissues (21), a significant
proportion of the downstream effects of reduced IIS in the
nervous system are FKH-dependent. However, whereas intesti-
nal FKH achieves some of its protective effects through up-
regulation of nutrient transporters (21), we find here that one
of the strongest FKH-dependent changes in the nervous system
is in the transcription of Atg17. Taken together with published
chromatin immunoprecipitation-sequencing studies identifying
the Atg17 genomic region as one bound by both FKH (55) and
FOXO (56), our results suggest that Atg17 could be a direct
target gene of FKH in neurons. Our further experiments show
here that increased expression of Atg17 in neurons is sufficient
on its own to extend lifespan. As the primary known function of
ATG17 is in the ATG1 kinase complex that initiates autophagy
(48), our results suggest that autophagy could be one beneficial
effect downstream of neuronal FKH, consistent with previous
studies and our own findings here showing that increased neu-
ronal expression of Atg1 (50) or Atg8 (57) can extend healthy
lifespan in Drosophila. In addition, increased neuronal auto-
phagy could be one pathway explaining how increased neuronal
fkh expression can mitigate some of the detrimental effects of Aβ
in neurons. Here too, our results are consistent with previous
studies showing beneficial effects of either genetic (58, 59) or
pharmacological (60) up-regulation of autophagy in animal
models of Aβ toxicity. However, the lack of marked changes in
insoluble ubiquitinated protein accumulation in fkh-overexpressing
flies during healthy aging (SI Appendix, Fig. S5) suggests either that
autophagy is not dramatically changed with neuronal fkh over-
expression in healthy aging or that more specific tools such as
fluorescently labeled endogenous ATG8A (61) may be needed to
adequately assess autophagy in aging.
Importantly, our results also open the door to other factors in
addition to autophagy that could contribute to the beneficial
effects of FKH on healthy lifespan. Our transcriptomic results
reveal a large number of genes whose response to lower IIS is
dependent on FKH, and many of these genes may contribute to
or be indicative of beneficial pathways downstream of FKH. For
instance, Cyp6a2, Cyp6w1, and Hsc70Cb are involved in stress
responses involving cytochrome P450-mediated xenobiotic de-
toxification and chaperone-mediated protein folding; their FKH-
dependent transcriptional regulation could indicate that these
would be fruitful pathways to pursue in future research on
neuron-mediated modulation of longevity. Other pathways be-
yond these genes could also be promising areas for study: For
example, both FOXO and FKH have been identified as mediators
of immune responses in Drosophila (21, 62–64). We propose that
deciphering the specific cell types in which either TF might be
acting in the immune response could therefore be key to uncov-
ering additional prolongevity factors regulated by FKH and FOXO.
Our findings have implications for research in other animal
species, where it will be important to consider whether the pat-
tern of TF expression among cell types is conserved for orthol-
ogous TFs. For example, mammalian genomes contain multiple
genes encoding both FOXA and FOXO family members, each
with distinct effects on age-related phenotypes (reviewed in ref.
65) that may result from their cell type-specific expression pat-
terns. Importantly, transcriptomic data from sorted neurons and
glial cell populations from both adult mouse (66) and adult hu-
man (67) brain tissues show gene expression patterns that only
partially match the patterns observed in Drosophila. These data
show low expression of FOXA family members in all mouse and
human brain cell types, with distinct expression patterns of
FOXO family members in different cell types including some
neuronal populations. These patterns are largely consistent with
previously observed effects of FOXO3 on autophagy in mouse
striatal neurons (68) and for FOXO6 in modulating memory
consolidation in mouse hippocampal neurons (69). However,
high-throughput datasets can miss vital genes expressed at low
levels or in small subpopulations of cells: For example, FOXA
family members are expressed in adult mouse midbrain dopa-
minergic neurons, where they play an important role in the
regulation of genes encoding essential enzymes for dopamine
biosynthesis (35). When considered in the context of our current
results, the cell type-specific expression patterns of TFs, as de-
termined by both high-throughput and targeted studies, will be
useful guides for future studies on aging and longevity.
Finally, our results underscore the need for future studies to
consider cell-type specificity of TF action in order to understand
physiological processes that involve multiple heterogeneous tis-
sues. In this regard, studies can draw on the growing knowledge
of cell type-specific TF action from established fields such as
immunology and endocrinology. For instance, recent studies
have identified the distinct TFs acting in regulatory T cells and T
helper 17 cells to mediate either antiinflammatory or proin-
flammatory transcriptional responses to transforming growth factor
β stimulation, respectively (70, 71). Similarly, estrogen signaling
achieves a plethora of outcomes in organ systems including car-
diovascular, musculoskeletal, and reproductive systems, in each
case via cell type-specific consequences of distinct TFs acting in
concert with the estrogen receptor (72, 73). Our results now add
neuronal FKH and glial FOXO activity downstream of IIS as an
additional example of how cell type-specific responses to similar
stimuli are maintained by distinct TF expression patterns.
In summary, we have identified neuronal FKH and glial
FOXO as cell type-specific targets to extend healthy lifespan in
Drosophila. Our results match the basal expression patterns for these
TFs, underscoring the need to consider where TFs are normally
active before using interventions that attempt to modulate their ac-
tivity. Cell type-specific effects will therefore be an essential consid-
eration for understanding and addressing the complexities of aging,
not only in the Drosophila nervous system but also in other hetero-
geneous tissues and ultimately in other species including humans.
Materials and Methods
Fly Stocks and Husbandry. Drosophila stocks were maintained and experi-
ments were conducted at 25 °C on a 12-h:12-h light:dark cycle at 65% hu-
midity, on food containing 10% (weight/volume; wt/vol) brewer’s yeast, 5%
(wt/vol) sucrose, and 1.5% (wt/vol) agar. The wild-type stock Dahomey was
collected in 1970 in Dahomey (now Benin) and has since been maintained in
large population cages with overlapping generations on a 12-h:12-h light:dark
cycle at 25 °C. The white Dahomey (wDah) stock was derived by incorporation
of the w1118 allele into the outbred Dahomey background by backcrossing. All
fly stocks in this study were backcrossed for six or more generations into the
outbred wDah background (Figs. 1, 2, 4, and 5) or an inbred w1118 background
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(Fig. 3). Additional information on stocks used and media preparation is
available in SI Appendix.
Survival Analysis. Lifespan assays were carried out as described in detail in ref.
74. Female flies were used for all experiments. From the eggs collected for
each set of parental crosses, the progeny that emerged as adults within a
24-h window were collected and allowed to mate for 48 h, after which they
were separated into single-sex vials containing either drug- or vehicle-
containing food at a density of 15 individuals per vial. Vials were kept ei-
ther individually or in DrosoFlippers (drosoflipper.com) for ease of regular
transfer to fresh vials. Flies were transferred to fresh vials three times per
week, with deaths and censors scored during each transfer. Microsoft Excel
(template described in ref. 74) was used to calculate survival proportions.
Additional Methods. Methods for other techniques (climbing, fecundity
measurements, immunofluorescence, RNA-seq, qPCR, and Western blots) are
available in SI Appendix.
Statistical Analysis. The statistical test used for each experiment is indicated in
the figure legends. Log-rank tests were performed in Microsoft Excel (tem-
plate described in ref. 74), and Cox proportional hazards tests were per-
formed in R using the survival package. ANOVA or t test analyses were
performed in GraphPad Prism 8.4. For all statistical tests, P < 0.05 was
considered significant.
Data Availability. The RNA-seq data analyzed in this article are freely available
at ArrayExpress (https://www.ebi.ac.uk/arrayexpress/) (accession no. E-MTAB-
9017) (75).
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